Chembio Diagnostics (Chembio Diagnostics) Days Sales Outstanding : 58.71 (As of Dec. 2022)

View and export this data going back to 2004. Start your Free Trial

What is Chembio Diagnostics Days Sales Outstanding?

Chembio Diagnostics's average Accounts Receivable for the three months ended in Dec. 2022 was $5.89 Mil. Chembio Diagnostics's Revenue for the three months ended in Dec. 2022 was $9.16 Mil. Hence, Chembio Diagnostics's Days Sales Outstanding for the three months ended in Dec. 2022 was 58.71.

The historical rank and industry rank for Chembio Diagnostics's Days Sales Outstanding or its related term are showing as below:

CEMI' s Days Sales Outstanding Range Over the Past 10 Years
Min: 41.56 Med: 59.44 Max: 85.36
Current: 56.43

During the past 13 years, Chembio Diagnostics's highest Days Sales Outstanding was 85.36. The lowest was 41.56. And the median was 59.44.

CEMI's Days Sales Outstanding is not ranked
in the Medical Diagnostics & Research industry.
Industry Median: 69.24 vs CEMI: 56.43

Chembio Diagnostics's Days Sales Outstanding increased from Dec. 2021 (46.94) to Dec. 2022 (58.71).

Chembio Diagnostics Days Sales Outstanding Historical Data

The historical data trend for Chembio Diagnostics's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chembio Diagnostics Days Sales Outstanding Chart

Chembio Diagnostics Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Days Sales Outstanding

Get a 7-Day Free Trial

49.92

59.57

42.18

73.23

67.87

Chembio Diagnostics Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22
Days Sales Outstanding	Get a 7-Day Free Trial															46.94	51.70	70.40	38.74	58.71

Competitive Comparison of Chembio Diagnostics's Days Sales Outstanding

For the Diagnostics & Research subindustry, Chembio Diagnostics's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chembio Diagnostics's Days Sales Outstanding Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Chembio Diagnostics's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Chembio Diagnostics's Days Sales Outstanding falls into.

Chembio Diagnostics Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Chembio Diagnostics's Days Sales Outstanding for the fiscal year that ended in Dec. 2022 is calculated as

	Days Sales Outstanding (A: Dec. 2022 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2021 )	+	Accounts Receivable (A: Dec. 2022 ))	/	count )	/	Revenue (A: Dec. 2022 )	*	Days in Period
=	( (11.441	+	6.536)	/	2 )	/	48.34	*	365
=	8.9885					/	48.34	*	365
=	67.87

Chembio Diagnostics's Days Sales Outstanding for the quarter that ended in Dec. 2022 is calculated as:

	Days Sales Outstanding (Q: Dec. 2022 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2022 )	+	Accounts Receivable (A: Dec. 2022 ))	/	count )	/	Revenue (A: Dec. 2022 )	*	Days in Period
=	( (5.253	+	6.536)	/	2 )	/	9.162	*	365 / 4
=	5.8945					/	9.162	*	365 / 4
=	58.71

Chembio Diagnostics (NAS:CEMI) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Chembio Diagnostics Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Chembio Diagnostics's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Chembio Diagnostics (Chembio Diagnostics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Chembio Diagnostics Inc (NAS:CEMI) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

3661 Horseblock Road, Medford, NY, USA, 11763

Website

http://www.chembio.com

Chembio Diagnostics Inc is a company that develops, manufactures, and commercializes point-of-care diagnostic tests that detect infectious diseases. The products of the company include rapid tests for the detection of HIV 1/2 antibodies and a multiplex rapid test for the detection of HIV and syphilis antibodies. The company offered rapid medical tests that are offered in Africa, Asia, Europe, and the Middle East, Latin America and the United States, of which key revenue is derived from Latin America.

Executives

Perceptive Credit Advisors, Llc	10 percent owner	51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Joseph Edelman	10 percent owner	C/O PERCEPTIVE ADVISORS LLC, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Perceptive Advisors Llc	10 percent owner	51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Leslie Teso-lichtman	director	C/O CHEMBIO DIAGNOSTICS, INC., 555 WIRELESS BOULEVARD, HAUPPAUGE NY 11788
Charles Caso	officer: See remarks	C/O CHEMBIO DIAGNOSTICS, INC., 555 WIRELESS BOULEVARD, HAUPPAUGE NY 11788
Paul Angelico	officer: See remarks	C/O CHEMBIO DIAGNOSTICS, INC., 555 WIRELESS BOULEVARD, HAUPPAUGE NY 11788
Lawrence J. Steenvoorden	officer: See remarks	C/O CHEMBIO DIAGNOSTICS, INC., 555 WIRELESS BOULEVARD, HAUPPAUGE NY 11788
David William Bespalko	director	29 CEDAR DRIVE, ALLENDALE NJ 07401
David Acheson	director	C/O CHEMBIO DIAGNOSTICS, INC., 555 WIRELESS BOULEVARD, HAUPPAUGE NY 11788
Richard Eberly	officer: See Remarks	3471 RIVER HILLS DRIVE, CINCINNATI OH 45244
John Gary Potthoff	director	6140 SPANISH OAKS CLUB BLVD., AUSTIN TX 78738
Javan Esfandiari	officer: Senior Vice President	3661 HORSEBLOCK ROAD, MEDFORD NY 11763
Robert Passas	officer: See Remarks	3661 HORSEBLOCK ROAD, MEDFORD NY 11763
Polan Mary Lake Ph D	director	STANFORD UNIVERSITY SCHOOL OF MEDICINE, 300 PASTAUR DR ROOM HH333, STANFORD CA 94305-5317
Neil A Goldman	officer: Executive VP and CFO	3661 HORSEBLOCK RD, MEDFORD NY 11763